22nd Century Group, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $642.7K
- Price
- $0.9001
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.15%
- Volume
- 11.4K
About
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
Quick stats
Shares outstanding714.0K
Computed float714.0K
Float / shares100.0%
Cash runway (months)1.9
Key info
SectorConsumer Defensive
IndustryTobacco
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001347858
Websitehttps://www.xxiicentury.com
AI Summary
AI-generated1/16
minorbullishregulatory
22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative
22nd Century Group highlighted an ANSES scientific assessment validating nicotine reduction in combustible tobacco and naming the company's plant-science approach as the only commercially available production path for very-low-nicotine cigarettes.
The report recommends a maximum nicotine limit across all combustible products in France, potentially at the EU level via revision of Directive 2014/40/EU; XXII says its non-GMO reduced-nicotine tobacco removes a key implementation barrier and is sourced at commercial scale.
The company estimates a French nicotine cap would convert a €20 billion+ retail market, with a sustainable legal market of roughly €8-13 billion over 3-5 years, but no rule is adopted and success depends on EU legislative action.
Red flags
- No binding regulation adopted; EU legislative proposals only expected before end of 2026
- Company-estimated €8-13B market opportunity assumes transition dynamics (illicit trade displacement, substitution) it cannot control
- Promotional framing: company-authored highlight of third-party report rather than issuer material development